Workshop - A strategy to acquire the data that will satisfy regulatory bodies

S. Stick (Perth, Australia)

Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

Number: 13

Disease area: Paediatric lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Stick (Perth, Australia). Workshop - A strategy to acquire the data that will satisfy regulatory bodies. Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary. Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013
Some principles and practices of genetic biobanking studies Source: Eur Respir J 2009; 33: 419-425 Year: 2009
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing Source: ERJ Open Res, 4 (1) 00108-2017; 10.1183/23120541.00108-2017 Year: 2018
Producing documents for the ERS: types, requirements and processes Source: Annual Congress 2013 –How to produce top quality ERS Guidelines Year: 2013
Data driven phenotyping and COVID-19 case definitions: a pattern recognition approach Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021
Reply to: When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed? Source: Eur Respir J, 58 (3) 2102020; 10.1183/13993003.02020-2021 Year: 2021
Application of big data technology for COVID-19: Panel discussion Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
When adopting Global Lung Function Initiative reference values, can we also adapt them to a local context as needed? Source: Eur Respir J, 58 (3) 2101601; 10.1183/13993003.01601-2021 Year: 2021
Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes Year: 2016
Extended criteria in donor selection: are we pushing the boundaries? Source: International Congress 2019 – Lung transplantation in 2019: where are we? Year: 2019
Research prioritisation in long COVID: using patients and experts to develop an international consensus Source: Virtual Congress 2021 – How science conquered COVID-19: from big platform trials to patients Year: 2021
Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
The impact of changing to the GLI reference equations on transfer factor results in children referred from a Haematology/Oncology service. Source: International Congress 2018 – Quality, reference values and standards Year: 2018